StorageVault to Acquire Six Assets for $71.8 Million, Exceeding $200 Million Completed and Announced Transactions for 2025

(TSX:SVI), TORONTO, Dec. 18, 2025 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault“) (SVI-TSX) is pleased to announce that it has agreed to acquire six assets from five vendor groups (collectively, the “Vendors“) for an aggregate purchase price of $71.8 million, subject to customary adjustments and due diligence conditions (the “Acquisitions“). Four of the transactions are […]

Domestic Metals 2025 Year End Update Grants Stock Options

(TSX-V:DMCU),(OTC US:DMCUF),(OTCQB:DMCUF),(Boerse Frankfurt – Freiverkehr:03E0.F), VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — Domestic Metals Corp. (the “Company” or “Domestic“) – (TSXV: DMCU; OTCQB: DMCUF; FSE: 03E) provides a 2025 Year End Update. Gord Neal, CEO of Domestic Metals Corp.: “2025 was a year of team organization and readying Domestic for a major porphyry

DMG Blockchain Solutions Reports Fourth Quarter and Full Year 2025 Audited Results

(TSX-V:DMGI),(OTC US:DMGGF),(Other OTC:DMGGF),(Frankfurt:6AX), VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG”), a vertically integrated blockchain and data center technology company, today announces its fiscal fourth quarter and full year audited 2025 financial results. All financial references are in Canadian Dollars unless specified

ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease

(NASDAQ:PMN), Large, well-powered Phase 1b study, designed to generate clinically and biologically meaningful insights in early Alzheimer's disease Clear and near-term value inflection points, with blinded 6-month interim data expected in Q2 2026 and final unblinded top-line results anticipated in Q4 2026 Cambridge, Massachusetts, Dec. 18, 2025 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (Nasdaq: PMN),

North American Niobium and Critical Minerals Corp. Expands Land Package In Quebec

(CNSX:NIOB),(CNSX:NIOB.CN),(Boerse Frankfurt – Freiverkehr:IOR),(OTC US:NIOMF),(Other OTC:NIOMF), Vancouver, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — North America Niobium and Critical Minerals Corp. (CSE: NIOB) (FSE: IOR) (OTCQB: NIOMF) (“North American Niobium” or the “Company”) is pleased to announce that it has acquired additional mineral properties in Quebec. The Company has (i) extended the Seigneurie Property

Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion

(NASDAQ:AVXL), NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that it has requested

Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference

(NASDAQ:RGEN), WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the J.P. Morgan 2026 Healthcare Conference, being held January 12 – 15 in San Francisco. Olivier Loeillot, President and Chief Executive Officer, will present an overview of

FuelCell Energy Ends FY2025 with Revenue Growth and a Focus on Data Center Opportunities

(NasdaqGM:FCEL), Fourth Quarter Fiscal 2025 Summary(All comparisons are year-over-year unless otherwise noted) Revenue of $55.0 million, compared to $49.3 million, an increase of approximately 12% Gross loss of $(6.6) million, compared to $(10.9) million, a decrease of approximately 39% Loss from operations of $(28.3) million, compared with $(41.0) million, a decrease of approximately 31% Net

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

(TSX:BCT),(NASDAQ:BCTX),(NASDAQ:BCTXW),(NASDAQ:BCTXZ), Nature Medicine asked leading researchers to name their top clinical trial for 2026, from long-awaited vaccines for infectious diseases to new treatments for advanced cancers and long COVID BriaCell's Phase 3 clinical trial in metastatic breast cancer featured as “clinical trial to watch in 2026” BriaCell anticipates reporting top line data as early as

Cartier Reports Significant Gold Resource Growth At Cadillac With 9,953,000 tonnes at a grade of 2.40g/t Au for 767,800 Ounces Measured and Indicated, a 7% Increase and 35,185,000 tonnes at a grade of 2.14g/t Au for 2,416,900 Ounces Inferred, a 48% Increase

(TSX-V:ECR),(Boerse Frankfurt – Freiverkehr:6CA), VAL-D'OR, Quebec, Dec. 18, 2025 (GLOBE NEWSWIRE) — Cartier Resources Inc. (“Cartier” or the “Company“) (TSXV: ECR; FSE: 6CA) is pleased to announce the results of the Updated Mineral Resource Estimate (“MRE”) on its 100% owned flagship Cadillac Project, located in Val-d'Or (Abitibi, Quebec). The updated estimates include approximately 110,000 metres

Scroll to Top